Related Articles
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects
Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder
Association between MDM2‑SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population
Meta‑analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk